Global Nitric Oxide Therapy Systems Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4564637
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Bellerophon Therapeutics
  • BOC Healthcare
  • Dan Hammer Health Ltd.
  • EKU Elektronik GmbH
  • GeNO, LLC
  • International Biomedical
  • MORE
Nitric Oxide Therapy Systems Market - Growth, Future Prospects, Competitive Analysis, 2017 - 2025, the global nitric oxide therapy systems market is expected to expand at a CAGR of 5.19 % from 2017 to 2025.

Market Insights
Nitric oxide is produced in the human body by an enzymatic reaction of nitric oxide synthase on L-arginine. Constitutive nitric oxide synthase and inducible nitric oxide synthase are 2 varieties formed in the human body. The deficiency of NOS causes pulmonary diseases such as neonate pulmonary hypertension and acute respiratory distress syndrome. Manufacturers are actively engaged in providing nitric oxide inhalation devices to overcome the complications of pulmonary ailments. INOpulse (Bellerophon Therapeutics) is automatically adjusted in accordance with the patients breathing pattern in order to deliver constant flow of nitric oxide at a fixed dose. Triple lumen nasal cannula is also provided to deliver accurate dose of nitric oxide to the ailing patient. maniNO (EKU Elektronik GmbH) provides blend of oxygen and nitric oxide with high precision and is applicable as manual ventilation, ambulatory services and MRI environment. The dosing capacity is from 0 ppm to 40 ppm and adjustable flow of 0 l/min to15 l/min.

Durability and lightweight are the meritorious features that increase the demand for portable nitric oxide therapy systems. Relatively low cost, versatility and easy fabrication of the auxiliary holding devices with the main ventilation unit makes fixed nitric oxide therapy systems a lucrative option in the ambulatory care and hospitals.

Hospitals and clinics widely utilize the nitric oxide inhalation therapy in the neonate and intensive care unit to address ailments related to pulmonary disorders and increasing demand for pediatric cardiopulmonary bypass surgery procedures for treating cardiopulmonary ailments. Homecare settings finds huge application of nitric oxide therapy systems for the rehabilitation of geriatric patients suffering with acute respiratory distress syndrome.

North America is the market leader in nitric oxide therapy systems due to the rising prevalence of acute respiratory distress syndrome in the adult population and the presence of key players actively engaged in the manufacturing of nitric oxide therapy systems. Asia Pacific will dominate the market in the near future on account of the rising prevalence of neonate pulmonary hypertension. Competitive market formed due to the emergence of local providers of nitric oxide therapy systems contribute to the growth of Asia Pacific market.

The manufacturers spearheading in the production of nitric oxide therapy systems are Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health Ltd., EKU Elektronik GmbH, GeNO LLC, International Biomedical, SLE, Mallinckrodt Pharmaceuticals, Praxair, Inc. and Vapotherm.

Key Market Movements:
  • Rising prevalence of neonatal pulmonary hypertension and acute respiratory distress syndrome
  • Recent technical advancements in the manufacturing of nitric oxide therapy systems will contribute to its market growth
  • Supportive regulatory environment for nitric oxide therapy systems
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bellerophon Therapeutics
  • BOC Healthcare
  • Dan Hammer Health Ltd.
  • EKU Elektronik GmbH
  • GeNO, LLC
  • International Biomedical
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Nitric Oxide Therapy Systems Market Portraiture
2.1.1. Global Nitric Oxide Therapy Systems Market, by Type, 2016
2.1.2. Global Nitric Oxide Therapy Systems Market, by End Users, 2016
2.1.3. Global Nitric Oxide Therapy Systems Market, by Geography, 2016

Chapter 3. Nitric Oxide Therapy Systems Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Porter’s Five Forces Analysis
3.6. Attractive Investment Proposition, by Geography
3.7. Top 3 Countries: Global Nitric Oxide Therapy Systems Market, 2015-2025 (US$ Mn)
3.8. Competitive Landscape: Global Nitric Oxide Therapy Systems Market, by Key Players, 2015-2025 (US$ Mn)

Chapter 4. Global Nitric Oxide Therapy Systems Market, by Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Competitive Analysis: Global Nitric Oxide Therapy Systems Market, by Type, 2016 Vs. 2025 (Value %)
4.2. Portable Nitric Oxide Therapy Systems
4.3. Fixed Nitric Oxide Therapy Systems

Chapter 5. Global Nitric Oxide Therapy Systems Market, by End Users, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Competitive Analysis: Global Nitric Oxide Therapy Systems Market, by End Users, 2016 Vs. 2025 (Value %)
5.2. Hospitals
5.3. Homecare Settings
5.4. Clinics

Chapter 6. Global Nitric Oxide Therapy Systems Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Nitric Oxide Therapy Systems Market Analysis, 2015 – 2025
6.2.1. North America Nitric Oxide Therapy Systems Market, by Type, 2015 – 2025 (US$ Mn)
6.2.2. North America Nitric Oxide Therapy Systems Market, by End Users, 2015 – 2025 (US$ Mn)
6.2.3. North America Nitric Oxide Therapy Systems Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Nitric Oxide Therapy Systems Market Analysis, 2015 – 2025
6.3.1. Europe Nitric Oxide Therapy Systems Market, by Type, 2015 – 2025 (US$ Mn)
6.3.2. Europe Nitric Oxide Therapy Systems Market, by End Users, 2015 – 2025 (US$ Mn)
6.3.3. Europe Nitric Oxide Therapy Systems Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Nitric Oxide Therapy Systems Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Nitric Oxide Therapy Systems Market, by Type, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Nitric Oxide Therapy Systems Market, by End Users, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Nitric Oxide Therapy Systems Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of APAC
6.5. Latin America Nitric Oxide Therapy Systems Market Analysis, 2015 – 2025
6.5.1. Latin America Nitric Oxide Therapy Systems Market, by Type, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Nitric Oxide Therapy Systems Market, by End Users, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Nitric Oxide Therapy Systems Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Nitric Oxide Therapy Systems Market Analysis, 2015 – 2025
6.6.1. MEA Nitric Oxide Therapy Systems Market, by Type, 2015 – 2025 (US$ Mn)
6.6.2. MEA Nitric Oxide Therapy Systems Market, by End Users, 2015 – 2025 (US$ Mn)
6.6.3. MEA Nitric Oxide Therapy Systems Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Bellerophon Therapeutics
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. BOC Healthcare
7.3. Dan Hammer Health Ltd.
7.4. EKU Elektronik GmbH
7.5. GeNO, LLC
7.6. International Biomedical
7.7. SLE
7.8. Mallinckrodt Pharmaceuticals
7.9. Praxair, Inc.
7.10. Vapotherm

List of Figures
FIG. 1 Nitric Oxide Therapy Systems: Market Segmentation
FIG. 2 Global Nitric Oxide Therapy Systems Market Share, by Type, 2016 (Value %)
FIG. 3 Global Nitric Oxide Therapy Systems Market, by End Users, 2016 (Value %)
FIG. 4 Global Nitric Oxide Therapy Systems Market Share, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2016
FIG. 7 Global Portable Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Fixed Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Hospitals Market for Nitric Oxide Therapy Systems, 2015 – 2025 (US$ Mn)
FIG. 10 Global Homecare Settings Market for Nitric Oxide Therapy Systems, 2015 – 2025 (US$ Mn)
FIG. 11 Global Clinics Market for Nitric Oxide Therapy Systems, 2015 – 2025 (US$ Mn)
FIG. 12 U.S. Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 13 Canada Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 14 U.K. Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 15 Germany Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 16 Rest of Europe Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 17 Japan Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 18 China Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 19 India Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 20 Rest of Asia Pacific Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 21 Brazil Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 22 Mexico Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 23 Rest of Latin America Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 24 GCC Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest of Middle East and Africa Nitric Oxide Therapy Systems Market, 2015 – 2025 (US$ Mn)

List of Tables
TABLE 1 Global Nitric Oxide Therapy Systems Market Portraiture
TABLE 2 Global Nitric Oxide Therapy Systems Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Nitric Oxide Therapy Systems Market, by End Users, 2015 – 2025 (US$ Mn)
TABLE 4 Global Nitric Oxide Therapy Systems Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 5 North America Nitric Oxide Therapy Systems Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Nitric Oxide Therapy Systems Market, by End Users, 2015 – 2025 (US$ Mn)
TABLE 7 North America Nitric Oxide Therapy Systems Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Nitric Oxide Therapy Systems Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Nitric Oxide Therapy Systems Market, by End Users, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Nitric Oxide Therapy Systems Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Nitric Oxide Therapy Systems Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Nitric Oxide Therapy Systems Market, by End Users, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Nitric Oxide Therapy Systems Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Nitric Oxide Therapy Systems Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America Nitric Oxide Therapy Systems Market, by End Users, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America Nitric Oxide Therapy Systems Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 17 Middle East and Africa Nitric Oxide Therapy Systems Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 18 Middle East and Africa Nitric Oxide Therapy Systems Market, by End Users, 2015 – 2025 (US$ Mn)
TABLE 19 Middle East and Africa Nitric Oxide Therapy Systems Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 20 Bellerophon Therapeutics: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 21 BOC Healthcare: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 22 Dan Hammer Health Ltd.: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 23 EKU Elektronik GmbH: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 24 GeNO LLC: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 25 International Biomedical: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 26 SLE: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 27 Mallinckrodt Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 28 Praxair, Inc.: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
TABLE 29 Vapotherm: Company Snapshot (Business Description; Financial Information; Type Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bellerophon Therapeutics
  • BOC Healthcare
  • Dan Hammer Health Ltd.
  • EKU Elektronik GmbH
  • GeNO, LLC
  • International Biomedical
  • SLE
  • Mallinckrodt Pharmaceuticals
  • Praxair, Inc.
  • Vapotherm
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll